{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:07:06Z","timestamp":1791810426380,"version":"4.3.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA2016CDF-1580"],"award-info":[{"award-number":["TMA2016CDF-1580"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW010132"],"award-info":[{"award-number":["D43TW010132"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-026-07703-y","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:44:52Z","timestamp":1770518692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The utility of urine lipoarabinomannan as a tuberculosis treatment monitoring tool in people living with HIV"],"prefix":"10.1186","volume":"19","author":[{"given":"Brian","family":"Otaalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Musaazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Nabisere-Arinaitwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakira","family":"Babirye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek J.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy","family":"Ssengooba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Nakiyingi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Castelnuovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari C.","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sekaggya-Wiltshire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"key":"7703_CR1","unstructured":"WHO Guidelines Approved by the Guidelines Review Committee. WHO consolidated guidelines on tuberculosis: Module 4: treatment\u2013tuberculosis care and support. Geneva: World Health Organization\u00a9 World Health Organization 2022. 2022."},{"issue":"5","key":"7703_CR2","first-page":"397","volume":"2","author":"JL Johnson","year":"1998","unstructured":"Johnson JL, Vjecha MJ, Okwera A, Hatanga E, Byekwaso F, Wolski K, et al. Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Int J Tuberculosis Lung Disease: Official J Int Union against Tuberculosis Lung Disease. 1998;2(5):397\u2013404. Makerere University-Case Western Reserve University Research Collaboration.","journal-title":"Int J Tuberculosis Lung Disease: Official J Int Union against Tuberculosis Lung Disease"},{"key":"7703_CR3","volume-title":"Lateral flow urine Lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy update (2019): evidence to decision tables","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Lateral flow urine Lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy update (2019): evidence to decision tables. World Health Organization: Geneva;; 2019."},{"issue":"1","key":"7703_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00408-012-9440-6","volume":"191","author":"C Naing","year":"2013","unstructured":"Naing C, Mak JW, Maung M, Wong SF, Kassim AI. Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis. Lung. 2013;191(1):27\u201334.","journal-title":"Lung"},{"issue":"4","key":"7703_CR5","doi-asserted-by":"publisher","first-page":"e006833","DOI":"10.1136\/bmjopen-2014-006833","volume":"5","author":"PK Drain","year":"2015","unstructured":"Drain PK, Gounder L, Grobler A, Sahid F, Bassett IV, Moosa MY. Urine Lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study. BMJ Open. 2015;5(4):e006833.","journal-title":"BMJ Open"},{"key":"7703_CR6","volume-title":"Uganda National tuberculosis and leprosy programme","author":"Ministry Of Health","year":"2017","unstructured":"Ministry Of Health. Manual for management and control of tuberculosis and leprosy. Uganda National tuberculosis and leprosy programme. editor. Third ed: Ministry of Health; 2017."},{"key":"7703_CR7","unstructured":"Ministry Of Health. Consolidated guidelines for the prevention and treatment of HIV in Uganda. Second ed. 2018."},{"issue":"1","key":"7703_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12879-015-1151-1","volume":"15","author":"S Bjerrum","year":"2015","unstructured":"Bjerrum S, Kenu E, Lartey M, Newman MJ, Addo KK, Andersen AB, et al. Diagnostic accuracy of the rapid urine Lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana\u2013findings from the DETECT HIV-TB study. BMC Infect Dis. 2015;15(1):407.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"7703_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12879-017-2313-0","volume":"17","author":"P Gina","year":"2017","unstructured":"Gina P, Randall PJ, Muchinga TE, Pooran A, Meldau R, Peter JG, et al. Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection. BMC Infect Dis. 2017;17(1):339.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-026-07703-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07703-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07703-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T11:05:23Z","timestamp":1773227123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13104-026-07703-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7703"],"URL":"https:\/\/doi.org\/10.1186\/s13104-026-07703-y","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Mulago Hospital Research and Ethics Committee (reference number: MHREC 1603), and all participants signed written informed consent. The study was also conducted in accordance with general principles outlined in the International Ethical Guidelines for Biomedical Research Involving Human Participants and the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication of de-identified data was informed and was obtained in written from all participants as part of the consenting process.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}